Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atreya Dash

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
European Urology|November 28, 2016
Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance StudyDaniel W Lin, Lisa F Newcomb, Marshall D Brown, et al.
Urology Practice|May 5, 2023
Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Lisa Newcomb, et al.
The Journal of Urology|June 15, 2014
Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsyMichael A Liss, Stephen A Taylor, Deepak Batura, et al.
Nutrition and Cancer|November 7, 2022
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance StudyJeannette M Schenk, Menghan Liu, Marian L Neuhouser, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)Lisa F Newcomb, Yingye Zheng, Anna V Faino, et al.
BJU International|January 28, 2015
The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial updateNorm D Smith, Erik P Castle, Mark L Gonzalgo, et al.
The Journal of Urology|December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
Clinical Genitourinary Cancer|January 29, 2023
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder CancerDimitrios Makrakis, Jonathan L Wright, Martine P Roudier, et al.
The American Journal of Managed Care|January 17, 2018
Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assayJulie A Lynch, Megan P Rothney, Raoul R Salup, et al.
The Journal of Urology|January 18, 2020
Reply by AuthorsJeannette M Schenk, Lisa F Newcomb, Yingye Zheng, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
European Urology|November 28, 2016
Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance StudyDaniel W Lin, Lisa F Newcomb, Marshall D Brown, et al.
Urology Practice|May 5, 2023
Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Lisa Newcomb, et al.
The Journal of Urology|June 15, 2014
Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsyMichael A Liss, Stephen A Taylor, Deepak Batura, et al.
Nutrition and Cancer|November 7, 2022
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance StudyJeannette M Schenk, Menghan Liu, Marian L Neuhouser, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)Lisa F Newcomb, Yingye Zheng, Anna V Faino, et al.
BJU International|January 28, 2015
The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial updateNorm D Smith, Erik P Castle, Mark L Gonzalgo, et al.
The Journal of Urology|December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
Clinical Genitourinary Cancer|January 29, 2023
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder CancerDimitrios Makrakis, Jonathan L Wright, Martine P Roudier, et al.
The American Journal of Managed Care|January 17, 2018
Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assayJulie A Lynch, Megan P Rothney, Raoul R Salup, et al.
The Journal of Urology|January 18, 2020
Reply by AuthorsJeannette M Schenk, Lisa F Newcomb, Yingye Zheng, et al.
Pageof 9